Rare diseases
Investigational molecules
Locations
Back to Czechia22 clinical trials in Broumov, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
CzechiaA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
CzechiaStudy of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups
CzechiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
CzechiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
CzechiaStudy on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction
CzechiaStudy on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension
CzechiaStudy of LY3556050 for Adults with Diabetic Peripheral Neuropathy Pain
CzechiaStudy on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension
CzechiaStudy on How Insulin Icodec and Semaglutide Help Control Blood Sugar in Patients with Type 2 Diabetes
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lipoprotein management and cardiovascular risk reduction in patients with established cardiovascular disease.
These trials aim to evaluate new therapeutic approaches for preventing heart attacks, strokes, and cardiovascular-related deaths.
Comprehensive studies examining innovative treatments for heart failure, particularly focusing on patients with reduced ejection fraction and kidney complications.
Research targets both efficacy and safety of novel therapeutic combinations to enhance patient outcomes.
Advanced clinical investigations into resistant hypertension management, exploring new treatment options for patients not responding to conventional therapies.
Studies focus on evaluating innovative medications for patients with difficult-to-treat high blood pressure.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
